NexgenRx Completes Equity Payment Issuance
Company Announcements

NexgenRx Completes Equity Payment Issuance

Story Highlights

NexgenRx (TSE:NXG) has released an update.

NexgenRx, a Canadian full-service Third-Party Administrator and Technology Solutions Provider, has announced the issuance of 195,312 common shares at $0.32 each, completing the fourth equity payment under its Consulting Agreement with PBM Management Services. The shares, which are part of the company’s compensation for consulting services, will be held for a statutory four-month period expiring November 19, 2024.

For further insights into TSE:NXG stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskNexgenRx Reports Strong Q2 Growth and SaaS Success
TipRanks Canadian Auto-Generated NewsdeskNexgenRx Announces Upcoming Dividend Payment
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App